info@biomedres.co   +1 (720) 414-3554   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA
ISSN: 2574 -1241

Impact Factor : 0.548

Impact Factor

e-Prints

Ilizarov Fixator in Treatment of Intertrochanteric Fracture Femur in Geriatric High Risk Patients

Research Article

Article Title:Ilizarov Fixator in Treatment of Intertrochanteric Fracture Femur in Geriatric High Risk Patients

Author: Ahmed Ibrahim Zayda

Published Date: January 24, 2018

DOI: 10.26717/BJSTR.2018.02.000688

Abstract: Objective: To assess the effectiveness of fixation of intertrochanteric fracture in geriatric high risk patients by Ilizarov fixator. Background: Internal fixation of intertrochanteric fractures in patients with anaesthetic or surgical risks has high complication rate, so external fixation should be considered as a semiconservative method to reduce operative time and complications. Patients and methods: Forty elderly high risk patients with intertrochanteric fracture were treated by Ilizarov fixator. All patients had uncontrolled concomitant medical disorders as hypertension, cardiac disease, diabetes mellitus and chronic hepatic or renal failure. Results: All patients were evaluated clinically & radiologically from 5 months to 12 months except 2 patients , one died 3 months post operative and the other lost follow up 3.5 month post operative after fixator removal. Excellent and good (satisfactory) results were found in 32 patients and fair and poor (unsatisfactory) results were found in 8 patients. The time of radiological union and fixator removal ranged from 10 weeks to 16 weeks. Pin tract infection occurred in all patients. Varus malalignment occurred in 20% of patients. Shortening ranged from 0 to 3 cm in 5 patients. Conclusion: the study proved that external fixation of intertrochanteric fractures in elderly high risk patients is a reliable, effective and safe treatment option. It offers a minimal operative risk, no blood loss, short hospital stay, early mobilization and low morbidity and mortality.